Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1993
11/16/1993US5262162 Cerebral-activating extract
11/16/1993CA1324382C Isoxazole-.beta.-carboline derivatives
11/16/1993CA1324378C Perhydroazacycloalka [1,2-a] imidazole derivatives and use thereof as nootropic agents
11/12/1993CA2095888A1 Methods for detecting beta amyloid precursor protein processing enzyme
11/11/1993WO1993022681A1 NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES
11/11/1993WO1993022436A1 Lectin domain variants of selectin
11/11/1993WO1993022424A1 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR
11/11/1993WO1993022328A1 Adenosine derivatives having a2 agonist activity
11/11/1993WO1993022310A1 (n-phthalimidoalkyl)piperidines for the treatment of psychoses
11/11/1993WO1993022309A1 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
11/11/1993WO1993022293A1 1-piperazino-1,2-dihydroindene derivatives
11/11/1993WO1993022279A1 Diamine derivatives having selective affinity for sigma receptors
11/11/1993WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993WO1993021916A1 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
11/11/1993WO1993021910A1 Use of remacemide for the treatment of parkinson's disease
11/11/1993WO1993017691A3 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
11/11/1993CA2134564A1 Recombinant stimulating factor of the neu receptor
11/11/1993CA2134227A1 Novel gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes
11/11/1993CA2134067A1 Adenosine derivatives having a2 agonist activity
11/11/1993CA2112490A1 Diamine derivatives having selective affinity for sigma receptors
11/10/1993EP0569333A2 Novel N-aralkyl and N-heteroaralkylamino alcane phosphinic acids
11/10/1993EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/10/1993EP0568575A1 Test and model for alzheimer's disease
11/10/1993EP0376986A4 Chemical splinter removal
11/09/1993US5260464 Carnitine derivatives, process for their preparation, and their use in human therapy
11/09/1993US5260314 Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties
11/09/1993US5260313 Diagnosis and treatment of various neuralgias
11/09/1993US5260298 Psychopharmaceuticals
11/09/1993US5260210 Blood-brain barrier model
11/09/1993CA2095499A1 Depot preparation
11/09/1993CA1324140C 2-phenyl-3-acylaminomethyl-5,6,7,8-tetrahydroimidazo [1,2-a]pyridine derivatives
11/09/1993CA1324139C 2-phenyl-3-acylaminomethyl-imidazo[1,2-a]pyridine derivatives
11/09/1993CA1324132C Oxyimino derivatives of thiazole, method of preparation and use in therapy
11/09/1993CA1324130C Oxaza heterocycles and pharmaceutical compositions containing same
11/03/1993EP0568437A1 Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones
11/03/1993EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates
11/03/1993EP0568208A1 Treatment of neurodegenerative diseases
11/03/1993EP0568136A1 Indole-2-carboxylic acid derivatives
11/03/1993EP0568026A2 Piroxicam tablets and production process thereof
11/03/1993EP0567767A1 Crystalline forms of endo-2,3-dihydro-N-(8-methyl-8-azabicyclo 3.2.1 oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3-ethyl-2,3-dihydro-N-(8-methyl-8-azabicyclo 3.2.1 oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride monohydrate as 5-HT antagonists
11/03/1993EP0567703A1 Treatment of neurodegenerative diseases
11/03/1993EP0359790B1 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation
11/03/1993CN1077952A Carbamate derivatives
11/02/1993US5258513 Substituted cyclopropylamino-1,3,5-triazines
11/02/1993US5258402 Imidate derivatives of sulfamates
11/02/1993US5258392 3-quinuclidine derivatives
11/02/1993US5258385 β-Carboline-derived compounds, lamchart benzodiazepine-receptor ligands, having an inverse agonist and antagonist effect on benzodiazepines, and drugs containing them
11/02/1993US5258378 Pyrroloazepine compounds useful as dopaminergic agents
10/1993
10/29/1993CA2095086A1 Piroxicam tablets and production process thereof
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993WO1993021219A1 Endothelin antagonists ii
10/28/1993WO1993021215A1 Peptides having tachykinin antagonist activity
10/28/1993WO1993021188A1 Delta opioid receptor-selective benzylidene-substituted morphinans for the treatment of alcohol abuse
10/28/1993WO1993021185A1 Substituted nitrogen containing spiro compounds for use in treating cognitive deficits
10/28/1993WO1993021180A1 Acylaminoindole derivatives as 5-ht1 agonists
10/28/1993WO1993021179A1 Novel amidoalkyl- and imidoalkyl-piperazines
10/28/1993WO1993021178A1 Indole derivatives as 5-ht1-like agonists
10/28/1993WO1993021177A1 Indole derivatives as 5-ht1-like agonists
10/28/1993WO1993021172A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
10/28/1993WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
10/28/1993WO1993021155A1 Perhydroisoindole derivatives as p substance antagonists
10/28/1993WO1993021153A1 Indole-2-carboxylic acid derivatives
10/28/1993WO1993020836A1 Treating disorders by application of insulin-like growth factors and analogs
10/28/1993WO1993020821A1 Agents for treating substance abuse disorders
10/28/1993WO1993020816A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
10/28/1993WO1993020812A1 Potentiation of antimicrobial effects
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993CA2133840A1 Perhydroisoindole derivatives used as p substance antagonists
10/28/1993CA2133090A1 Endothelin antagonists ii
10/28/1993CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/28/1993CA2118503A1 Peptides having tachykinin antagonist activity
10/28/1993CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993CA2118212A1 Substituted nitrogen containing spiro compounds for use in treating cognitive deficits
10/28/1993CA2117498A1 Indole derivatives as 5-ht1-like agonists
10/28/1993CA2110911A1 Treating disorders by application of insulin-like growth factors and analogs
10/28/1993CA2109816A1 Novel amidoalkyl- and imidoalkyl-piperazines
10/27/1993EP0567251A1 Treatment of neurodegenerative diseases
10/27/1993EP0567250A1 Treatment of neurodegenerative diseases
10/27/1993EP0567107A1 Quinoline and quinazoline derivatives for treating arthritis
10/27/1993EP0566709A1 Composition comprising a tramadol compound and acetaminophen, and its use
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0504180B1 Glycyl-p-amino-pyridine for the treatment of senile dementia states
10/27/1993CN1022566C Process for preparation of substituted 1-piperidylalkylene-pyridopyrimidone or thiazolpyrimidone
10/26/1993US5256824 Substituted-amine compound and a process for the preparation thereof
10/26/1993US5256698 Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives
10/26/1993US5256682 Anxiolytic agents
10/26/1993US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation
10/26/1993US5256664 Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
10/26/1993CA2033975C Use of .beta.-receptor blocking agents
10/25/1993CA2094774A1 Pharmaceutical composition containing quinoline and quinazoline derivatives and novel compounds therefor
10/25/1993CA2094548A1 Aminoalcohols-n-acylderivatives as therapeutical agents against the neurogenic endoneural oedema developing at the peripheral nerve
10/20/1993EP0566393A1 Stabilized solid pharmaceutical preparation and method of producing the same
10/20/1993EP0565965A2 Benzo b thiophen-5-yl derivative and process for producing the same
10/20/1993EP0565732A1 Benzodioxane derivative
10/20/1993EP0565683A1 Quinoxaline derivates with affinity for quisqualate-receptors
10/20/1993EP0565634A1 Angiotensin ii receptor blocking compositions
10/20/1993EP0565579A1 2-imino 6-polyfluoralkyl 3-heterocyclylalkyl benzothiazoline derivatives, their preparation and drugs containing same.
10/20/1993EP0565557A1 1-(4-acylaminophenyl)-7,8-methylenedioxy-5h-2,3-benzo-diazepine derivatives and acid addition salts thereof, pharmaceutical compositions containing them and process for preparing same